GC/MS DRS Controlled Substances Screener (CAT#: AM-LE-0276-Y)

GC/MS DRS Controlled Substances Screener is manufactured by Agilent Technologies and provides an RTL method for analyzing prohibited target drugs. The DRS library contains 460 compounds, including new psychostimulants, bath salts and synthetic cannabinoids. DRS can automatically distinguish target analytes and matrices, and can accurately identify controlled drugs, thereby reducing the need for manual data analysis.

• Pre-configuration and chemical testing of verification sample analysis to ensure the best performance and reliable identification of controlled drug analysis
• Improve analysis efficiency by shortening the analysis cycle (135 minutes), and use DRS to automatically identify target analytes in the background, even for complex matrices
• The new generation deconvolution report software (DRS) library contains 460 controlled drugs
• Inert flow path can improve the analytical performance of low-concentration sensitive analytes, expand the quantitative and detection range
• Optimized for the analysis of controlled drugs, including gas chromatography columns, consumables, calibration samples and analytical methods
• Simple operation, technicians can be trained on site

220-MS GC Ion Trap Mass Spectrometer from Agilent Technologies 5975C Series GC/MSD System from Agilent Technologies
GC/MS Residual Solvent Analyzers from Agilent Technologies Polymer Grade Monomer Analyzers from Agilent Technologies